Alternatives to Excalipoint Therapeutics

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.

Developing oral small molecule medicines for immunological and chronic diseases.

Clinical-stage biotech company targeting RNA modifications for novel cancer therapies.

Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.

Immunotherapy company targeting oncology and autoimmune diseases.

A biotechnology company focused on oncology drug discovery.

Clinical-stage immunotherapy company developing novel treatments for cancer.

Advancing targeted alpha therapies.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

Developing a pipeline of cancer therapeutics delivered directly into the cytosol of tumor cells.

Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.

Biopharmaceutical company developing T-cell therapies for solid tumor cancers.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Pioneering next-generation bispecific ADCs for cancer treatment.

Biotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Enzyme-based technology to break down alcohol in the stomach.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A global leader in clinical pharmacology and bioanalytical sciences.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

A biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

Advancing deupirfenidone as a potential new standard of care for Idiopathic Pulmonary Fibrosis (IPF).

AI-native biotech company designing next-generation CAR T therapies for solid tumors.

Developing highly targeted, small molecule medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

A pharmaceutical company focused on developing long-acting injectable medicines.

Advancing next-generation mRNA medicines.

AI-powered antibody discovery platform.

A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.

Developing a new class of anti-IgE therapy for multiple atopic conditions.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Provides regulated, secure, and high-yield digital asset solutions for institutional and corporate treasuries.

A biotechnology company focused on developing novel enzyme-based therapies for reflux disease.